Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity of a xenogeneic multi-epitope HER2+ breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205
Aytül Gül, Mert Döşkaya, Hüseyin Can, et al.
Vaccine (2022) Vol. 40, Iss. 16, pp. 2409-2419
Closed Access | Times Cited: 11

Showing 11 citing articles:

Targeting dendritic cells to advance cross-presentation and vaccination outcomes
Christophe Macri, Devi Jenika, Cassandra Ouslinis, et al.
Seminars in Immunology (2023) Vol. 68, pp. 101762-101762
Closed Access | Times Cited: 31
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy
Yijie Wang, Congrui Liu, Chao Fang, et al.
Nano-Micro Letters (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
State-of-the-Art Review on Liposomes as Versatile Cancer Vaccine Delivery Systems
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
Peptides for diagnosis and treatment of ovarian cancer
Ling Guo, Jing Wang, Nana Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools
Ahmet Efe Köseoğlu, Hüseyin Can, Mervenur Güvendi, et al.
Biologicals (2024) Vol. 85, pp. 101749-101749
Open Access | Times Cited: 2
Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production
Aytül Gül, Sedef Erkunt Alak, Hüseyin Can, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Designing a Novel Multiepitope Vaccine from the Human Papilloma Virus E1 and E2 Proteins for Indonesia with Immunoinformatics and Molecular Dynamics Approaches
Rizarullah Rizarullah, Reza Aditama, Ernawati Arifin Giri-Rachman, et al.
ACS Omega (2024) Vol. 9, Iss. 14, pp. 16547-16562
Open Access | Times Cited: 1
A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis
Ceren Gül, Aytül Gül, Tuğba Karakavuk, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126065-126065
Closed Access | Times Cited: 1
Transcriptional Targeting of Dendritic Cells Using an Optimized Human Fascin1 Gene Promoter
Yanira Zeyn, Dominika Hobernik, Ulrich Wilk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16938-16938
Open Access | Times Cited: 1
An optimized ROP6 mRNA construct successfully expressed immunogenic Toxoplasma gondii ROP6 protein in cell culture
Sedef Erkunt Alak, Ceren Gül, Mervenur Güvendi, et al.
Gene (2024) Vol. 935, pp. 149073-149073
Closed Access
Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools
Ahmet Efe Köseoğlu, Hüseyin Can, Mervenur Güvendi, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top